THAP1 and Dystonia: Specifically, these data strongly support the notion that disease-causing mutations in THAP1 generate loss-of-function alleles which are unable to regulate target gene expression: 84% of the missense mutations in THAP1 identified in dystonia patients exhibited performance at <50% of the wild-type protein.